Eric Breumier

Eric Breumier is a seasoned executive with extensive experience in the pharmaceutical industry, currently serving as the Head of Greater China and CEO of Ferring China at Ferring Pharmaceuticals since September 2013. Breumier's career includes prominent roles at Covidien as Vice President of Global Pipeline Management, Head of Global Marketing at Galderma, and various leadership positions at Bristol Myers Squibb, where responsibilities included being the Global Lead for Dapagliflozin and General Manager for India. Breumier's early career features roles with Ciba-Geigy, where significant market-share growth was achieved under management. Educational credentials include an MBA in International Business from the University of Leicester and a BA in Business from IAE Caen, among other qualifications in health care and management.